Rankings
▼
Calendar
OCGN Q1 2025 Earnings — Ocugen, Inc. Revenue & Financial Results | Market Cap Arena
OCGN
Ocugen, Inc.
$578M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
+46.1% YoY
Gross Profit
$1M
100.0% margin
Operating Income
-$15M
-979.1% margin
Net Income
-$15M
-1036.5% margin
EPS (Diluted)
$-0.05
QoQ Revenue Growth
+93.8%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$64M
Total Liabilities
$49M
Stockholders' Equity
$16M
Cash & Equivalents
$38M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$1M
+46.1%
Gross Profit
$1M
$1M
+46.1%
Operating Income
-$15M
-$12M
-18.7%
Net Income
-$15M
-$12M
-28.7%
← FY 2025
All Quarters
Q2 2025 →